Shares of Praxis Precision Medicines more than tripled Thursday, peaking at $200 apiece, after the company disclosed positive ...

Praxis Precision Medicines said on Thursday its experimental drug for movement disorder helped patients improve their ability to perform daily tasks in two late-stage trials, sending its shares ...

Praxis Precision Medicines said on Thursday its experimental drug for a type of movement disorder improved patients' ability to perform daily tasks in two late-stage trials, sending its shares surging ...

Shares of Praxis Precision Medicines skyrocketed 184% Thursday on "groundbreaking" test results for an essential tremor ...

Standardized, repeatable testing underpins everything we review at PCMag. Here's how we evaluate desktop CPUs, from pure ...

The Northeast is becoming a key e-commerce market in India, with Amazon and Flipkart expanding operations to meet rising ...

We take a closer look at the unique Apogee One bike and take a tour of the brand's machine shop with one of the founders.

Deals: Novo Nordisk is set to buy a blood disease drug from Omeros for up to $2.1 billion. Bristol Myers Squibb acquired Orbital Therapeutics for $1.5 billion. Boehringer Ingelhei ...

After finishing an online bachelor's degree in educational studies for paraprofessionals, April Rummel is now pursuing an online master's program in special education through the U of A Global Campus.

Fintel reports that on October 17, 2025, Truist Securities reiterated coverage of Praxis Precision Medicines (NasdaqGS:PRAX) ...

Bolstered by a late-stage trial win for its essential tremor drug, Praxis Precision Medicines Inc. is looking to raise $525 ...

We recently published Market Downturn? Not for these 10 Stocks; 7 Jump to Record Highs. Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is one of the best performers on Thursday. Praxis Precision ...